Jim Simons's position in Corbus Pharmaceuticals Holdings is currently worth $2.75M. That's 0.00% of their equity portfolio (1702nd largest holding). The investor owns 2.73% of the outstanding Corbus Pharmaceuticals Holdings stock. The first Corbus Pharmaceuticals Holdings trade was made in Q1 2024. Since then Jim Simons bought shares four more times and sold shares on four occasions. The investor's estimated purchase price is $4.3M, resulting in a loss of 36%.